CD276 antibody (C-Term)
Quick Overview for CD276 antibody (C-Term) (ABIN2797904)
Target
See all CD276 AntibodiesReactivity
Host
Clonality
Conjugate
Application
- 
    
- 
                                            
Binding Specificity
 - AA 493-522, C-Term
 - 
                                            
Purpose
 - Rabbit Anti-Human CD276 (C-term) Antibody
 - 
                                            
Immunogen
 - This CD276 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 493-522 amino acids from the C-terminal region of human CD276.
 - 
                                            
Isotype
 - Ig Fraction
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Application Notes
 - 
                        Western Blot
Recommended Dilutions
WB: 1:1000CD276 Antibody (C-term) . - 
                                            
Restrictions
 - For Research Use only
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Liquid
 - 
                                            
Concentration
 - 0.5 mg/mL
 - 
                                            
Storage
 - 4 °C,-20 °C
 - 
                                            
Storage Comment
 - 2-8°C (short-term), -20°C (long-term)
 
 - 
                                            
 - 
    
- CD276
 - 
                                            
Alternative Name
 - CD276
 - 
                                            
Background
 - 
                        
Target Description: Costimulatory B7 Molecules (e.g., B7-1, or CD80, MIM 112203) signal through CD28 (MIM 186760) family molecules such as CD28, CTLA4 (MIM 123890), and ICOS (MIM 604558).
Gene Symbol: CD276
 - 
                                            
Molecular Weight
 - 57235 Da
 - 
                                            
Gene ID
 - 80381
 - 
                                            
UniProt
 - Q5ZPR3
 - 
                                            
Pathways
 - Cancer Immune Checkpoints
 
Target
 -